Roberto Maj
11Patents
3h-index
15Co-inventors
57Inventor score
Filing activity: May 21, 1987 → Sep 29, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9173935B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 20 | Active |
| US5912242A | N-(4-substituted-benzyl)-2-aminolactam derivatives | Chemistry; Metallurgy | 6 | Expired |
| US4785001A | Ergoline esters | Human Necessities | 4 | Expired |
| US9540407B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 3 | Active |
| US9173936B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 2 | Active |
| US9180183B2 | Phospholipid drug analogs | Emerging Cross-Sectional Technologies | 2 | Active |
| US9050319B2 | Phospholipid drug analogs | Human Necessities | 2 | Active |
| US8084447B2 | Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use | Human Necessities | 1 | Expired |
| US9066940B2 | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | Emerging Cross-Sectional Technologies | 0 | Active |
| US9107919B2 | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration | Emerging Cross-Sectional Technologies | 0 | Active |
| US8710040B2 | Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.